Market analyst Reportlinker.com has added a new report to its catalogue ‘Molecular Diagnostics - Technologies, Markets and Companies’. The report is also available in its website.
The report studies and analyzes molecular diagnostics technologies that could affect medicine, public health, pharmaceutical industry, forensics and biological warfare. It incorporates polymerase chain reaction (PCR)-based technologies, fluorescent in -situ hybridization (FISH), peptide nucleic acids (PNA), electrochemical DNA detection, biochips, nanotechnology and proteomic technologies.
Molecular diagnostics are used in genetic disorders, pre-implantation screening and cancer. Genetic screening testing could be used to laboratory diagnostics. It is being combined with therapeutics to offer integrated healthcare. Its technologies also help develop personalized medication on the lines of pharmacogenetics and pharmacogenomics.
The report identifies and analyzes key players in molecular diagnostics. Over 500 companies have been listed, of which 310 are profiled while 689 collaborations have been tabled. Development in this field has mostly occurred in the US.
The markets in this field overlap with those for non-molecular diagnostic technologies in the laboratory environment. The report provides market analysis for the 2010 categorized by technologies, applications and geographical areas. Market predictions over a ten year period, trends and developments in genomics and proteomics have been included. The report also estimates that biochip and nanobiotechnology will enable growth of molecular diagnostics.
Source: http://www.reportlinker.com